Eupatilin is widely used in the treatment of various gastrointestinal disorders due to its anti-inflammatory and antioxidant properties. It is particularly effective in managing gastritis and peptic ulcers by reducing inflammation and protecting the gastric mucosa from damage. Additionally, eupatilin has shown potential in alleviating symptoms of irritable bowel syndrome (IBS) by modulating gut motility and reducing intestinal spasms. Its ability to inhibit the release of pro-inflammatory cytokines makes it a valuable component in formulations aimed at treating inflammatory bowel diseases like Crohn's disease and ulcerative colitis. Beyond gastrointestinal applications, eupatilin is being researched for its potential anti-cancer properties, particularly in inhibiting the growth of certain cancer cells. Its therapeutic benefits continue to be explored in various medical fields.